Influence of platelet and white blood cell counts on major thrombosis – analysis from a patient registry in essential thrombocythemiaVeronika Buxhofer‐Ausch, Heinz Gisslinger, Michael Steurer et al.|European Journal Of Haematology|2016Cited by 42
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemiaVeronika Buxhofer‐Ausch, Heinz Gisslinger, Reinhard Ruckser et al.|European Journal Of Haematology|2018Cited by 18
Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemiaVeronika Buxhofer‐Ausch, Heinz Gisslinger, Dominik Wolf et al.|European Journal Of Haematology|2020Cited by 16
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen—Single-Center AnalysisSigrid Machherndl‐Spandl, Veronika Buxhofer‐Ausch, Sarah Hannouf et al.|Cancers|2024Cited by 4
Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic MyelofibrosisSigrid Machherndl‐Spandl, Veronika Buxhofer‐Ausch, Marcel Kiehberger et al.|Cancers|2025Cited by 1